buthionine sulfoximine has been researched along with Carcinoma, Anaplastic in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (22.22) | 18.7374 |
1990's | 4 (44.44) | 18.2507 |
2000's | 1 (11.11) | 29.6817 |
2010's | 2 (22.22) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bahar, M; Khaghani, S; Khorramizadeh, MR; Mirmiranpour, H; Nejad, SG; Paknejad, M; Pasalar, P | 1 |
Ardail, D; Boivin, A; Hanot, M; Maalouf, M; Malesys, C; Rodriguez-Lafrasse, C; Rousson, R | 1 |
Boku, Y; Hara, T; Kokura, S; Naito, Y; Nakagawa, S; Yoshida, N; Yoshikawa, T | 1 |
Biaglow, JE; McPherson, S; Mitchell, JB; Russo, A | 1 |
Chow, S; Hedley, DW | 1 |
Kang, YJ | 2 |
de Vries, EG; Hospers, GA; Meijer, C; Mulder, NH; Uges, DR | 1 |
Andrews, PA; Howell, SB; Murphy, MP | 1 |
9 other study(ies) available for buthionine sulfoximine and Carcinoma, Anaplastic
Article | Year |
---|---|
Exogenous coenzyme Q10 modulates MMP-2 activity in MCF-7 cell line as a breast cancer cellular model.
Topics: Acetylcysteine; Biomarkers; Breast Neoplasms; Buthionine Sulfoximine; Carcinoma; Cell Line, Tumor; Down-Regulation; Enzyme Inhibitors; Female; Free Radical Scavengers; Glutamate-Cysteine Ligase; Humans; Hydrogen Peroxide; Matrix Metalloproteinase 2; Osmolar Concentration; Oxidation-Reduction; Oxidative Stress; Time Factors; Ubiquinone | 2010 |
Transient alteration of cellular redox buffering before irradiation triggers apoptosis in head and neck carcinoma stem and non-stem cells.
Topics: Adaptation, Physiological; Apoptosis; bcl-2-Associated X Protein; Buffers; Buthionine Sulfoximine; Carcinoma; Carcinoma, Squamous Cell; Cell Line, Tumor; Dimethyl Fumarate; Fumarates; Glutathione; Head and Neck Neoplasms; Humans; JNK Mitogen-Activated Protein Kinases; MAP Kinase Kinase Kinase 5; Neoplasms, Squamous Cell; Neoplastic Stem Cells; Oxidation-Reduction; Squamous Cell Carcinoma of Head and Neck | 2011 |
Enhancement of lipid peroxidation and of the antitumor effect of hyperthermia upon combination with oral eicosapentaenoic acid.
Topics: Administration, Oral; Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antioxidants; Arachidonic Acids; Buthionine Sulfoximine; Carcinoma; Drug Screening Assays, Antitumor; Fatty Acids, Unsaturated; Glutathione Peroxidase; Hyperthermia, Induced; Lipid Peroxidation; Liver; Liver Neoplasms, Experimental; Male; Oxidation-Reduction; Rats; Stimulation, Chemical; Thiobarbituric Acid Reactive Substances | 2002 |
Cellular glutathione depletion by diethyl maleate or buthionine sulfoximine: no effect of glutathione depletion on the oxygen enhancement ratio.
Topics: Animals; Buthionine Sulfoximine; Carcinoma; Cell Line; Cells, Cultured; Cricetinae; Dose-Response Relationship, Radiation; Glutathione; Humans; Hypoxia; Lung; Lung Neoplasms; Maleates; Methionine Sulfoximine; Oxygen Consumption; Radiation-Sensitizing Agents; Time Factors | 1983 |
Evaluation of methods for measuring cellular glutathione content using flow cytometry.
Topics: Animals; Breast Neoplasms; Bridged Bicyclo Compounds; Buthionine Sulfoximine; Carcinoma; Carcinosarcoma; CHO Cells; Colonic Neoplasms; Cricetinae; Ethylmaleimide; Eukaryotic Cells; Evaluation Studies as Topic; Flow Cytometry; Fluoresceins; Fluorescent Dyes; Glutathione; Humans; Maleates; Mammary Neoplasms, Experimental; Methionine Sulfoximine; Mice; o-Phthalaldehyde; Phenylmercury Compounds; Pyrazoles; Species Specificity; Tumor Cells, Cultured; Urinary Bladder Neoplasms | 1994 |
Exogenous glutathione attenuates the antiproliferative effect of buthionine sulfoximine.
Topics: Antimetabolites, Antineoplastic; Buthionine Sulfoximine; Carcinoma; Cell Division; Cystine; Glutathione; Humans; Lung Neoplasms; Methionine Sulfoximine; Tumor Cells, Cultured | 1994 |
Buthionine sulfoximine enhances glutathione-but attenuates glutamate-stimulated cell proliferation.
Topics: Antimetabolites, Antineoplastic; Buthionine Sulfoximine; Carcinoma; Cell Division; Culture Media; Enzyme Inhibitors; Glutamic Acid; Glutathione; Humans; Lung Neoplasms; Methionine Sulfoximine; Tumor Cells, Cultured | 1995 |
The role of glutathione in resistance to cisplatin in a human small cell lung cancer cell line.
Topics: Antimetabolites; Buthionine Sulfoximine; Carcinoma; Cell Line; Cell Nucleus; Cell Survival; Cisplatin; DNA; DNA Repair; Dose-Response Relationship, Drug; Drug Resistance; Glutathione; Humans; Lung Neoplasms; Methionine Sulfoximine; Neoplasm Proteins | 1990 |
Differential potentiation of alkylating and platinating agent cytotoxicity in human ovarian carcinoma cells by glutathione depletion.
Topics: Alkylating Agents; Buthionine Sulfoximine; Carcinoma; Cell Line; Drug Resistance; Drug Synergism; Female; Glutathione; Humans; Methionine Sulfoximine; Organoplatinum Compounds; Ovarian Neoplasms | 1985 |